SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Genstruct Applying Epistemics Approach To 'Molecular World' (BioWorld Today)
News | 01. 20. 2004
Genstruct Inc. is approaching a drug discovery obstacle in a thoroughly modern way, that is, with what it calls “logical models” of biological systems designed to uncover and define compound mechanisms of action and disease mechanisms.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.